Since their discovery 20 years ago, microRNAs have been related to posttranscriptional
regulation of gene expression in major cardiac physiological and pathological processes …

Hypertrophic cardiomyopathy (HCM) is the most common genetically determined heart
pathology and is often accompanied by fatal complications. Today, the traditional view of the …

Myasthenia gravis (MG) is an autoimmune disease and the most common type of
neuromuscular disease. Genes and miRNAs associated with MG have been widely studied; …

Background Epidemiological and experimental studies suggest that preeclampsia has a
negative impact on maternity and offspring health. Previous studies report that dysregulation …

Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disease that affects 1 in
every 200 people in the general population, leading to cardiac ischemia, heart failure and …

Objectives: Some ceRNA associated with lncRNA have been considered as possible
diagnostic and therapeutic biomarkers for obstructive sleep apnea (OSA). We intend to …

Signal transducer and activator of transcription 3 (STAT3), an important transcription factor
and signaling molecule, play an important role in cardiac disease and protection. As a …

Background. Neuropeptide levels are closely associated with the development and
maintenance of atrial fibrillation (AF) after myocardial infarction (MI). This study was aimed at …

Hypertrophic cardiomyopathy (HCM) is characterized by abnormal thickening of the
myocardium, leading to arrhythmias, heart failure, and elevated risk of sudden cardiac …

Familial hypertrophic cardiomyopathy (HCM) is a significant precursor of heart failure and
sudden cardiac death, primarily caused by mutations in sarcomeric and structural proteins …